US Patent 7645799 Substituted biaryl compounds as factor XIa inhibitors

Patent 7645799 was granted and assigned to Bristol-Myers Squibb on January, 2010 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Bristol-Myers Squibb

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

7645799

Patent Inventor Names

James R. Corte0

Donald J. P. Pinto0

Joanne M. Smallheer0

Mimi L. Quan0

Date of Patent

January 12, 2010

Patent Application Number

12266659

Date Filed

November 7, 2008

Patent Citations Received

‌

US Patent 12012464 Factor XI antibodies and methods of use

Patent Primary Examiner

‌

Rebecca L Anderson

Patent abstract

The present invention provides compounds of Formula (I):

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7645799 Substituted biaryl compounds as factor XIa inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API